IE782018L - Alkylthiopenoxypropanolamines - Google Patents

Alkylthiopenoxypropanolamines

Info

Publication number
IE782018L
IE782018L IE782018A IE201878A IE782018L IE 782018 L IE782018 L IE 782018L IE 782018 A IE782018 A IE 782018A IE 201878 A IE201878 A IE 201878A IE 782018 L IE782018 L IE 782018L
Authority
IE
Ireland
Prior art keywords
alkyl
gb2006197a
alkylthiophenoxypropanolamines
cycloalkyl
administered
Prior art date
Application number
IE782018A
Other versions
IE47449B1 (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IE782018L publication Critical patent/IE782018L/en
Publication of IE47449B1 publication Critical patent/IE47449B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/32Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Alkylthiophenoxypropanolamines of the general formula:- <IMAGE> (A,B,R = H,C1-4 alkyl; R1=C1-8 alkyl R2 = C6-12 alkyl, (C5-8 cycloalkyl) - (C2-6 alkyl) ) and the pharmaceutically acceptable acid addition salts thereof increase peripheral blood flow, relax vascular smooth muscle, and inhibit platelet aggregation. They may be administered in the form of pharmaceutical preparations for the treatment of obstructive cerebrovascular deficiencies. [GB2006197A]
IE2018/78A 1977-10-11 1978-10-10 Alkylthiophenoxypropanolamines IE47449B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84116877A 1977-10-11 1977-10-11
US94222278A 1978-09-14 1978-09-14

Publications (2)

Publication Number Publication Date
IE782018L true IE782018L (en) 1979-04-11
IE47449B1 IE47449B1 (en) 1984-03-21

Family

ID=27126241

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2018/78A IE47449B1 (en) 1977-10-11 1978-10-10 Alkylthiophenoxypropanolamines

Country Status (21)

Country Link
JP (1) JPS6049188B2 (en)
AR (2) AR224239A1 (en)
AU (1) AU520181B2 (en)
CA (1) CA1116636A (en)
CH (1) CH642349A5 (en)
DE (1) DE2844353C2 (en)
DK (1) DK146005C (en)
ES (1) ES474156A1 (en)
FI (1) FI70883C (en)
FR (1) FR2405932A1 (en)
GB (1) GB2006197B (en)
GR (1) GR73919B (en)
IE (1) IE47449B1 (en)
IL (1) IL55695A (en)
IT (1) IT1109310B (en)
LU (1) LU80345A1 (en)
NL (1) NL7810156A (en)
NO (1) NO146161C (en)
PH (1) PH15824A (en)
SE (1) SE443782B (en)
YU (1) YU41602B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396629A (en) 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6504268A (en) * 1965-04-03 1966-10-04
DE2551141A1 (en) * 1975-11-14 1977-05-18 Dolorgiet Arzneimittelfabrik (1)-Cyclododecylamino'(2)-hydroxy-propane derivs. - selective beta-receptor blockers
DE2552266A1 (en) * 1975-11-21 1977-05-26 Dolorgiet Arzneimittelfabrik (1)-Aryloxy or arylthio-(3)-cyclohexylamino-(2)-propanol derivs. - prepd. e.g. by reacting epoxy propane cpds. with (3,3,5)-trimethyl-cyclohexylamine

Also Published As

Publication number Publication date
SE443782B (en) 1986-03-10
AR224239A1 (en) 1981-11-13
IT7851437A0 (en) 1978-10-10
AU520181B2 (en) 1982-01-21
NO146161C (en) 1982-08-11
FI70883B (en) 1986-07-18
NO146161B (en) 1982-05-03
NO783416L (en) 1979-05-25
IL55695A0 (en) 1978-12-17
JPS5488232A (en) 1979-07-13
YU235278A (en) 1983-01-21
AR223016A1 (en) 1981-07-15
IT1109310B (en) 1985-12-16
DK146005C (en) 1989-05-29
FR2405932A1 (en) 1979-05-11
NL7810156A (en) 1979-04-17
AU4039378A (en) 1980-04-17
IL55695A (en) 1982-01-31
FR2405932B1 (en) 1981-03-20
DK450978A (en) 1979-04-12
ES474156A1 (en) 1979-10-16
DE2844353C2 (en) 1984-01-26
GB2006197A (en) 1979-05-02
CH642349A5 (en) 1984-04-13
FI783068A (en) 1979-04-12
FI70883C (en) 1986-10-27
IE47449B1 (en) 1984-03-21
DE2844353A1 (en) 1979-04-19
PH15824A (en) 1983-04-08
JPS6049188B2 (en) 1985-10-31
LU80345A1 (en) 1979-06-15
YU41602B (en) 1987-12-31
GB2006197B (en) 1982-01-27
SE7810574L (en) 1979-04-12
DK146005B (en) 1983-05-16
GR73919B (en) 1984-05-22
CA1116636A (en) 1982-01-19

Similar Documents

Publication Publication Date Title
Waziri Glycine therapy of schizophrenia.
KR900700089A (en) Pharmaceutical Compositions for Systemic Skin Permeable Administration
AU7643591A (en) A pharmaceutical preparation
IL77186A0 (en) Pharmaceutical insulin composition
NO166448C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOLIDE INDIANS.
IE904035A1 (en) Medicaments containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses
IE790951L (en) Carnitine solution
WO2001012214A3 (en) MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a)
ATE55248T1 (en) DRUG COMBINATION.
ATE104146T1 (en) DELAYED-RELEASE PREPARATION OF A HYDROCHLORIDE OF A BASIC DRUG.
IE782018L (en) Alkylthiopenoxypropanolamines
DE69015910D1 (en) Pharmaceutical use of fatty acids.
EP0294914A3 (en) Nedocromil for the treatment of dermatological disorders
KR910002442A (en) Methods and pharmaceutical compositions for treating ocular disease
Vlachakis et al. Treatment of essential hypertension with trimazosin, a new vasodilator agent.
KR890012942A (en) 5-substituted ornithine derivatives
EP0471388A3 (en) Medicament for the treatment of cardiac insufficiency
FR2244481A1 (en) Oral treatment of diabetes - with a complex of glibenclamide and phenformin
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
JPS56131514A (en) Ketoprofen composition for rectum administration
SU1162440A1 (en) Method of treatment of infectious complications of patients with burns
US3806594A (en) Method of reducing involuntary movements associated with cerebral palsy using clorazepate dipotassium
RU2003136156A (en) PHARMACEUTICAL COMBINATION COMPRISING EITHER (S) -2-ethoxy-3- [4- (2- {4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid or 3- {4- [2- (4-TRETBUTOKSIKARBONILAMINOFENIL) ethoxy] Phenyl} - (S) -ethoxypropionic acid and insulin
MILNER et al. Diltiazem for the treatment of thyrotoxicosis
SU862955A1 (en) Method of treating child&#39;sbronchitis